The MOG Project (@TheMOGProject) header
The MOG Project (@TheMOGProject) profile picture

We collaborate with national & international Doctors & Researchers around the world to help educate & provide research about #MOGAD. 501(c)3 🌺 #ViewsAreOurOwn

United States
Joined April 2020
Photo by The MOG Project (@TheMOGProject)Photo by The MOG Project (@TheMOGProject)Photo by The MOG Project (@TheMOGProject)Photo by The MOG Project (@TheMOGProject)Photo by The MOG Project (@TheMOGProject)Photo by The MOG Project (@TheMOGProject)Photo by The MOG Project (@TheMOGProject)Photo by The MOG Project (@TheMOGProject)Photo by The MOG Project (@TheMOGProject)Photo by The MOG Project (@TheMOGProject)
How does MOGAD affect daily life for children and families around the world? The global IMPACT Survey invites young people ages 12–20 with MOGAD and parents/guardians of those ages 0–20 to share their experiences. Anonymous. 20–30 min. Take part: redcap.link/impact-survey Sponsored by UCB.
1
1
3
527
Let’s debate! Do you consider a pt who has pain, but no vision loss as an ON attack? Would you treat these pts despite no vision loss? We are torn between different practises treating eye pain without vision loss classifying it as ‘ON’ / others are not
38%Yes ON / would treat
33%Not ON / would not treat
10%50/50 send help
19%Stay tuned for research
21 votes • Final results
1
1
3
455
The MOG Project retweeted
Researchers comparing longitudinal trajectories of global & regional brain atrophy across MS, MOGAD, & AQP4 + NMOSD found that each exhibit distinct patterns of brain structural evolution. Read the full study with all the findings here: hubs.la/Q04CtK-h0
14
40
3,470
For clinicians: TIMELY-PLEX: Does early plasma exchange improve recovery after severe optic neuritis or myelitis? Refer within 14 days of symptom onset. See participating sites to refer patients at timely-plex.org The MOG Project serves as an advocacy principal investigator. NCT07100990: clinicaltrials.gov/study/NCT… #MOGAD
1
7
14
648
🧠 Bilateral thalamic lesions in a child. Unilateral cortical swelling with seizures. Longitudinally extensive myelitis with conus involvement. Different imaging patterns. One disease. (MOGAD) This week's #SPIN tweetorial explores its expanding MRI spectrum. 🧵👇
10
27
1
110
6,077
The MOG Project retweeted
Replying to @chenmayo
@chenmayo with a great presentation at #MSTORONTO2026 on #MOGAD treatments including his pioneering approach of “steroid in the pocket” acutely to get in early & prevent disability while also covering observational & clinical trial data on attack-prevention treatments👇
4
1
26
579
The MOG Project retweeted
Excellent talk on pediatric #MS #MOGAD a& #NMOSD from @tweetsatakash covering all the latest in acute & maintenance treatment of these diseases along with emerging clinical trials in the field 👇
4
17
738
Welcome Dr. Haiwen Chen to The MOG Project’s Medical & Scientific Advisory Council! A pediatric neuroimmunologist at Johns Hopkins, Dr. Chen combines clinical MOGAD research with laboratory studies exploring how brain cells influence neuronal communication. Meet Dr. Chen: mogproject.org/medical-advis… #MOGAD
1
7
491
The MOG Project retweeted
🧠 Satralizumab (Enspryng) reduced relapse risk by 68% vs placebo in the phase 3 METEOROID trial in relapsing MOGAD 📊 At 48 weeks, 87.3% of patients receiving satralizumab remained relapse-free vs 66.5% with placebo 🔬 Findings from #CNS2026: hubs.li/Q04BpK2J0 #MOGAD #Neurology
7
15
863
The MOG Project retweeted
Delighted to share our international review on MRI Characteristics of #MOGAD! ➡️ Key imaging features are highlighted across the brain, optic nerves & spinal cord including lesion dynamics ➡️ Illustrative figures help show its full imaging spectrum👇 jamanetwork.com/journals/jam…
9
84
2
238
21,392
The MOG Project retweeted
This retrospective cohort study with a preplanned analysis found that prednisolone ≥10 mg treatment for ≥3 months after the index event was associated with a lower likelihood of relapsing MOGAD: hubs.la/Q04w51LN0
17
56
4,362
The MOG Project retweeted
Children can develop the full spectrum of MOGAD-like encephalitis without MOG-IgG. Clinical features and immunotherapy response are similar to MOGAD, but relapses are uncommon: hubs.la/Q04vrm6_0
22
2
93
11,581
The MOG Project retweeted
Hacohen et al. review and assess the current evidence, make clinical considerations, and propose future directions for treatment de-escalation and discontinuation in MOGAD and AQP4-Ab NMOSD: hubs.la/Q04vs21q0
34
1
80
9,672
The MOG Project retweeted
Become an @ISNI_neuro member now to be eligible for travel awards to join us in beautiful Venice. More update on the program soon. #WeAreNeuroimmunology
Make the most of your experience at the 18th International Congress of Neuroimmunology in Venice. ISNI members enjoy: • Reduced Congress registration rates • Eligibility to apply for Travel Awards • Early access to registration Complimentary membership is available for all new and renewing members through the end of 2026, so you can start taking advantage of these benefits today. 🔗 Become a member: isniweb.org/become-a-member #WeAreNeuroimmunology #Neuroimmunology #ISNICongress2027
4
15
558
The MOG Project retweeted
Nos vemos hoy! @NeuroinmunUC
🧠 ¿Cómo han cambiado las opciones terapéuticas para la NMOSD y el MOGAD en los últimos años? La quinta sesión de NMOSD Focus Sessions reunirá a dos expertas internacionales para analizar los tratamientos inmunosupresores e inmunomoduladores disponibles y su aplicación en la práctica clínica. 📚 Tratamientos inmunosupresores / inmunomoduladores de la NMOSD y MOGAD 🎙️ Dra. Maria Sepúlveda – Neuróloga, Hospital Clínic de Barcelona (España) 🎙️ Dra. Ethel Ciampi – Neuróloga, Pontificia Universidad Católica de Chile, Hospital Sótero del Río (Chile) Moderada por: 🔹 Dra. Georgina Arrambide – Neuróloga, Cemcat (Barcelona) 📅 Miércoles, 16 de septiembre de 2026 🕒 15:00–16:00 h (CEST) 🌐 Online | Español 🔗 Regístrate: bit.ly/NMOSDFocusSessions202… #NMOSD #MOGAD #Neuroinmunología #Neurología #MedicalEducation #CemcatEducation
2
10
1,042
Antibody-associated disorders such MOGAD and NMOSD rely on antibody tests for their diagnosis, rendering accessibility to testing paramount to the care and treatment of people with MOGAD and NMOSD. ISNI is pleased to support a worldwide survey on AQP4- and MOG-IgG testing accessibility and laboratory testing strategies with the aiming of mapping the current access to AQP4-IgG and MOG-IgG testing and to understand issues that limit testing access around the world. Two surveys are available: one for neurologists who request testing and the other one for head scientists and immunopathologists who provide the testing. Please consider spending 12 minutes to complete one of the surveys. Learn more & access the survey here: isniweb.org/testing-survey @FabienneBrilot , Paddy Waters, matteo gastaldi, @SaraMariottoMD and @hwiendl #MOGantibodyTaskForce
4
1
15
1,520
The MOG Project retweeted
Antibody-associated disorders such MOGAD and NMOSD rely on antibody tests for their diagnosis, rendering accessibility to testing paramount to the care and treatment of people with MOGAD and NMOSD. ISNI is pleased to support a worldwide survey on AQP4- and MOG-IgG testing accessibility and laboratory testing strategies with the aiming of mapping the current access to AQP4-IgG and MOG-IgG testing and to understand issues that limit testing access around the world. Two surveys are available: one for neurologists who request testing and the other one for head scientists and immunopathologists who provide the testing. Please consider spending 12 minutes to complete one of the surveys. Learn more & access the survey here: isniweb.org/testing-survey @FabienneBrilot , Paddy Waters, matteo gastaldi, @SaraMariottoMD and @hwiendl #MOGantibodyTaskForce
1
3
7
534
A step forward for MOGAD: FDA granted Priority Review to Enspryng® (satralizumab) — potentially the first MOGAD treatment. Trial: 68% lower relapse risk vs placebo. FDA decision expected Jan 10 2027. gene.com/media/press-release…
2
3
1
11
592